{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    6,
    8,
    17,
    20,
    25,
    26,
    29,
    37,
    38,
    39
  ],
  "modelUsed": "claude-opus-4-5",
  "confidence": 0.9,
  "amendmentDetails": {
    "studyAmendmentImpacts": [
      {
        "id": "impact_1",
        "amendmentId": "amend_3.1_US",
        "affectedSection": "Section 1.3 Schedule of Activities (SoA), Table 1",
        "impactLevel": "Minor",
        "instanceType": "StudyAmendmentImpact",
        "description": "Addition of footnote text stating that procedures specific to screening sites (only in the US) are detailed in Section 8"
      },
      {
        "id": "impact_2",
        "amendmentId": "amend_3.1_US",
        "affectedSection": "Section 4.2 Scientific Rationale for Study Design",
        "impactLevel": "Administrative",
        "instanceType": "StudyAmendmentImpact",
        "description": "Correction of number of days from 30 days to 21 days regarding zinc discontinuation timing"
      },
      {
        "id": "impact_3",
        "amendmentId": "amend_3.1_US",
        "affectedSection": "Section 8 Study Assessments and Procedures",
        "impactLevel": "Major",
        "instanceType": "StudyAmendmentImpact",
        "description": "Addition of text applicable only to the US detailing the possibility for sites in the US to only perform screening procedures and not any of the remaining study procedures"
      }
    ],
    "studyAmendmentReasons": [
      {
        "id": "reason_1",
        "amendmentId": "amend_3.1_US",
        "reasonText": "To clarify study procedures occurring across different sites in the US, so as to facilitate participant recruitment across different regions of the US, and to lessen inconvenience for participants without compromising the quality of the study",
        "category": "Operational",
        "isPrimary": true,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_2",
        "amendmentId": "amend_3.1_US",
        "reasonText": "To align the number of days with the mention of zinc discontinuation elsewhere in the protocol",
        "category": "Administrative",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      },
      {
        "id": "reason_3",
        "amendmentId": "amend_3.1_US",
        "reasonText": "To facilitate participant recruitment across different regions of the US and to lessen inconvenience for participants without compromising the quality of the study",
        "category": "Operational",
        "isPrimary": false,
        "instanceType": "StudyAmendmentReason"
      }
    ],
    "studyChanges": [
      {
        "id": "change_1",
        "amendmentId": "amend_3.1_US",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "1.3",
        "afterText": "Procedures specific to screening sites (only in the US) detailed in Section 8",
        "summary": "Added footnote text to Schedule of Activities table referencing US-specific screening site procedures in Section 8"
      },
      {
        "id": "change_2",
        "amendmentId": "amend_3.1_US",
        "changeType": "Modification",
        "instanceType": "StudyChange",
        "sectionNumber": "4.2",
        "beforeText": "However, the physiologic turnover of human gastrointestinal epithelial cells is 3 - 5 days (Darwich, 2014); therefore, the inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 30 days after discontinuation of zinc.",
        "afterText": "However, the physiologic turnover of human gastrointestinal epithelial cells is 3 - 5 days (Darwich, 2014); therefore, the inhibitory effect of zinc on intestinal copper absorption is expected to be minimal 21 days after discontinuation of zinc.",
        "summary": "Changed zinc discontinuation timing from 30 days to 21 days to align with other protocol references"
      },
      {
        "id": "change_3",
        "amendmentId": "amend_3.1_US",
        "changeType": "Addition",
        "instanceType": "StudyChange",
        "sectionNumber": "8",
        "afterText": "Text applicable only to the US that details the possibility for sites in the US to only perform screening procedures and not any of the remaining study procedures",
        "summary": "Added US-specific text allowing certain sites to perform only screening procedures to facilitate recruitment across different US regions"
      }
    ],
    "summary": {
      "impactCount": 3,
      "reasonCount": 3,
      "changeCount": 3
    }
  }
}